Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.

Aschauer C, Jelencsics K, Hu K, Heinzel A, Vetter J, Fraunhofer T, Schaller S, Winkler S, Pimenov L, Gualdoni GA, Eder M, Kainz A, Regele H, Reindl-Schwaighofer R, Oberbauer R.

BMC Nephrol. 2019 Sep 2;20(1):346. doi: 10.1186/s12882-019-1541-5.

2.

TUBULAR ECTASIA IN RENAL ALLOGRAFT BIOPSY- ASSOCIATIONS WITH OCCULT OBSTRUCTIVE UROLOGICAL COMPLICATIONS.

Bojic M, Regele H, Herkner H, Berlakovich G, Kläger J, Bauer C, Seitz C, Kikić Ž.

Transplantation. 2019 Mar 4. doi: 10.1097/TP.0000000000002699. [Epub ahead of print]

PMID:
31343566
3.

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.

Eskandary F, Dürr M, Budde K, Doberer K, Reindl-Schwaighofer R, Waiser J, Wahrmann M, Regele H, Spittler A, Lachmann N, Firbas C, Mühlbacher J, Bond G, Halloran PF, Chong E, Jilma B, Böhmig GA.

Trials. 2019 Jan 11;20(1):37. doi: 10.1186/s13063-018-3158-6.

4.

European Association of Urology Guidelines on Renal Transplantation: Update 2018.

Rodríguez Faba O, Boissier R, Budde K, Figueiredo A, Taylor CF, Hevia V, Lledó García E, Regele H, Zakri RH, Olsburgh J, Breda A.

Eur Urol Focus. 2018 Mar;4(2):208-215. doi: 10.1016/j.euf.2018.07.014. Epub 2018 Jul 20.

PMID:
30033070
5.

Allograft rejection is associated with development of functional IgE specific for donor MHC antigens.

Farkas AM, Baranyi U, Böhmig GA, Unger L, Hopf S, Wahrmann M, Regele H, Mahr B, Schwarz C, Hock K, Pilat N, Kristo I, Mraz J, Lupinek C, Thalhamer J, Bond G, Kuessel L, Wlodek E, Martin J, Clatworthy M, Pettigrew G, Valenta R, Wekerle T.

J Allergy Clin Immunol. 2019 Jan;143(1):335-345.e12. doi: 10.1016/j.jaci.2018.06.034. Epub 2018 Aug 9.

6.

Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.

Hevia V, Boissier R, Rodríguez-Faba Ó, Fraser-Taylor C, Hassan-Zakri R, Lledo E, Regele H, Buddde K, Figueiredo A, Olsburgh J, Breda A.

Eur Urol Focus. 2018 Mar;4(2):153-162. doi: 10.1016/j.euf.2018.05.010. Epub 2018 Jun 18.

PMID:
29921544
7.

Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis.

Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Medinger M, Sørensen SS, Dauber EM, Böhmig G, Regele H, Berlakovich GA, Wekerle T, Oberbauer R.

Am J Transplant. 2019 Feb;19(2):475-487. doi: 10.1111/ajt.14970. Epub 2018 Jul 13.

8.

Blockade of adhesion molecule lymphocyte function-associated antigen-1 improves long-term heart allograft survival in mixed chimeras.

Pilat N, Sabler P, Klaus C, Mahr B, Unger L, Hock K, Wiletel M, Schwarz C, Kristo I, Regele H, Wekerle T.

J Heart Lung Transplant. 2018 Sep;37(9):1119-1130. doi: 10.1016/j.healun.2018.03.016. Epub 2018 Mar 30.

PMID:
29699851
9.

Effectiveness and Harms of Using Kidneys with Small Renal Tumors from Deceased or Living Donors as a Source of Renal Transplantation: A Systematic Review.

Hevia V, Hassan Zakri R, Fraser Taylor C, Bruins HM, Boissier R, Lledo E, Regele H, Budde K, Figueiredo A, Breda A, Yuan CY, Olsburgh J.

Eur Urol Focus. 2019 May;5(3):508-517. doi: 10.1016/j.euf.2018.01.018. Epub 2018 Feb 9. Review.

PMID:
29433988
10.

Lymphotoxin expression in human and murine renal allografts.

Seeger H, Lindenmeyer MT, Cohen CD, Jaeckel C, Nelson PJ, Chen J, Edenhofer I, Kozakowski N, Regele H, Boehmig G, Brandt S, Wuethrich RP, Heikenwalder M, Fehr T, Segerer S.

PLoS One. 2018 Jan 4;13(1):e0189396. doi: 10.1371/journal.pone.0189396. eCollection 2018.

11.

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, Hidalgo LG, Haslacher H, Kaltenecker CC, Aretin MB, Oberbauer R, Posch M, Staudenherz A, Handisurya A, Reeve J, Halloran PF, Böhmig GA.

J Am Soc Nephrol. 2018 Feb;29(2):591-605. doi: 10.1681/ASN.2017070818. Epub 2017 Dec 14.

12.

Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.

Eskandary F, Jilma B, Mühlbacher J, Wahrmann M, Regele H, Kozakowski N, Firbas C, Panicker S, Parry GC, Gilbert JC, Halloran PF, Böhmig GA.

Am J Transplant. 2018 Apr;18(4):916-926. doi: 10.1111/ajt.14528. Epub 2017 Oct 31.

13.

The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.

Boissier R, Hevia V, Bruins HM, Budde K, Figueiredo A, Lledó-García E, Olsburgh J, Regele H, Taylor CF, Zakri RH, Yuan CY, Breda A.

Eur Urol. 2018 Jan;73(1):94-108. doi: 10.1016/j.eururo.2017.07.017. Epub 2017 Aug 10. Review.

PMID:
28803033
14.

Anti-Interleukin-6 Promotes Allogeneic Bone Marrow Engraftment and Prolonged Graft Survival in an Irradiation-Free Murine Transplant Model.

Granofszky N, Farkas AM, Muckenhuber M, Mahr B, Unger L, Maschke S, Pilat N, Holly R, Wiletel M, Regele H, Wekerle T.

Front Immunol. 2017 Jul 19;8:821. doi: 10.3389/fimmu.2017.00821. eCollection 2017.

15.

Regulatory T Cells Promote Natural Killer Cell Education in Mixed Chimeras.

Mahr B, Pilat N, Maschke S, Granofszky N, Schwarz C, Unger L, Hock K, Farkas AM, Klaus C, Regele H, Wekerle T.

Am J Transplant. 2017 Dec;17(12):3049-3059. doi: 10.1111/ajt.14342. Epub 2017 Jun 6.

16.

Disturbances in iron homeostasis result in accelerated rejection after experimental heart transplantation.

Resch T, Ashraf MI, Ritschl PV, Ebner S, Fabritius C, Brunner A, Schäfer G, Regele H, Günther J, Weiss G, Kotsch K.

J Heart Lung Transplant. 2017 Jul;36(7):732-743. doi: 10.1016/j.healun.2017.03.004. Epub 2017 Mar 7.

PMID:
28372951
17.

Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection: Associations With Levels of Donor-Specific Antibodies and Chronic Allograft Injury.

Kozakowski N, Eskandary F, Herkner H, Bond G, Oberbauer R, Regele H, Böhmig GA, Kikić Ž.

Transplantation. 2017 May;101(5):e178-e187. doi: 10.1097/TP.0000000000001707.

PMID:
28252564
18.

Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study.

Wahrmann M, Mühlbacher J, Marinova L, Regele H, Huttary N, Eskandary F, Cohen G, Fischer GF, Parry GC, Gilbert JC, Panicker S, Böhmig GA.

Am J Transplant. 2017 Sep;17(9):2300-2311. doi: 10.1111/ajt.14256. Epub 2017 Mar 31.

19.

miR-182-5p Inhibition Ameliorates Ischemic Acute Kidney Injury.

Wilflingseder J, Jelencsics K, Bergmeister H, Sunzenauer J, Regele H, Eskandary F, Reindl-Schwaighofer R, Kainz A, Oberbauer R.

Am J Pathol. 2017 Jan;187(1):70-79. doi: 10.1016/j.ajpath.2016.09.011. Epub 2016 Nov 18.

PMID:
27870928
20.

MELAS Syndrome and Kidney Disease Without Fanconi Syndrome or Proteinuria: A Case Report.

Rudnicki M, Mayr JA, Zschocke J, Antretter H, Regele H, Feichtinger RG, Windpessl M, Mayer G, Pölzl G.

Am J Kidney Dis. 2016 Dec;68(6):949-953. doi: 10.1053/j.ajkd.2016.06.027. Epub 2016 Sep 24.

PMID:
27683045
21.

The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses.

Schwarz C, Unger L, Mahr B, Aumayr K, Regele H, Farkas AM, Hock K, Pilat N, Wekerle T.

Am J Transplant. 2016 Dec;16(12):3404-3415. doi: 10.1111/ajt.13872. Epub 2016 Jul 5.

22.

Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.

Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA.

Transplantation. 2017 Mar;101(3):631-641. doi: 10.1097/TP.0000000000001195.

PMID:
27120452
23.

Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.

Bauer E, Schlederer M, Scheicher R, Horvath J, Aigner P, Schiefer AI, Kain R, Regele H, Hoermann G, Steiner G, Kenner L, Sexl V, Villunger A, Moriggl R, Stoiber D.

Oncotarget. 2016 Mar 15;7(11):12191-205. doi: 10.18632/oncotarget.7687.

24.

Renal microRNA- and RNA-profiles in progressive chronic kidney disease.

Rudnicki M, Perco P, D Haene B, Leierer J, Heinzel A, Mühlberger I, Schweibert N, Sunzenauer J, Regele H, Kronbichler A, Mestdagh P, Vandesompele J, Mayer B, Mayer G.

Eur J Clin Invest. 2016 Mar;46(3):213-26. doi: 10.1111/eci.12585. Epub 2016 Jan 21.

PMID:
26707063
25.

Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation.

Ashraf MI, Schwelberger HG, Brendel KA, Feurle J, Andrassy J, Kotsch K, Regele H, Pratschke J, Maier HT, Aigner F.

Am J Transplant. 2016 Mar;16(3):808-20. doi: 10.1111/ajt.13521. Epub 2015 Nov 23.

26.

The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.

Seleznik G, Seeger H, Bauer J, Fu K, Czerkowicz J, Papandile A, Poreci U, Rabah D, Ranger A, Cohen CD, Lindenmeyer M, Chen J, Edenhofer I, Anders HJ, Lech M, Wüthrich RP, Ruddle NH, Moeller MJ, Kozakowski N, Regele H, Browning JL, Heikenwalder M, Segerer S.

Kidney Int. 2016 Jan;89(1):113-26. doi: 10.1038/ki.2015.280. Epub 2016 Jan 4.

PMID:
26398497
27.

Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?

Böhmig GA, Kikic Z, Wahrmann M, Eskandary F, Aliabadi AZ, Zlabinger GJ, Regele H, Feucht HE.

Clin Biochem. 2016 Mar;49(4-5):394-403. doi: 10.1016/j.clinbiochem.2015.05.024. Epub 2015 Jun 26. Review.

PMID:
26118475
28.

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.

Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1435-43. doi: 10.2215/CJN.09901014. Epub 2015 Jun 12.

29.

The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss.

Kozakowski N, Herkner H, Böhmig GA, Regele H, Kornauth C, Bond G, Kikić Ž.

Kidney Int. 2015 Aug;88(2):332-40. doi: 10.1038/ki.2015.64. Epub 2015 Mar 4.

30.

Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.

Adam B, Randhawa P, Chan S, Zeng G, Regele H, Kushner YB, Colvin RB, Reeve J, Mengel M.

Am J Transplant. 2014 Sep;14(9):2137-47. doi: 10.1111/ajt.12794. Epub 2014 Aug 4.

31.

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.

Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, Böhmig GA.

Trials. 2014 Apr 3;15:107. doi: 10.1186/1745-6215-15-107.

32.

Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT Trial.

Eskandary F, Bond G, Regele H, Kozakowski N, Kikić Z, Wahrmann M, Haslacher H, Oberbauer R, Ramassar V, Halloran P, Böhmig GA.

Clin Transpl. 2014:189-95.

PMID:
26281144
33.

Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allografts.

Kikić Z, Kozakowski N, Regele H, Priessner K, Nordmeyer V, Marinova L, Zlabinger GJ, Wahrmann M, Bartel G, Böhmig GA.

Transpl Int. 2014 Mar;27(3):312-21. doi: 10.1111/tri.12254. Epub 2014 Jan 16.

34.

Pre-implant biopsy predicts outcome of single-kidney transplantation independent of clinical donor variables.

Hofer J, Regele H, Böhmig GA, Gutjahr G, Kikić Z, Mühlbacher F, Kletzmayr J.

Transplantation. 2014 Feb 27;97(4):426-32. doi: 10.1097/01.tp.0000437428.12356.4a.

PMID:
24285339
35.

Known players, new interplay in atherogenesis: Chronic shear stress and carbamylated-LDL induce and modulate expression of atherogenic LR11 in human coronary artery endothelium.

Bajari TM, Winnicki W, Gensberger ET, Scharrer SI, Regele H, Aumayr K, Kopecky C, Gmeiner BM, Hermann M, Zeillinger R, Sengölge G.

Thromb Haemost. 2014 Feb;111(2):323-32. doi: 10.1160/TH12-12-0924. Epub 2013 Nov 28.

PMID:
24284991
36.

The ERA-EDTA Database on Recurrent Glomerulonephritis following renal transplantation.

Floege J, Regele H, Gesualdo L; ERA-EDTA Immunonephrology Working Group.

Nephrol Dial Transplant. 2014 Jan;29(1):15-21. doi: 10.1093/ndt/gft299. Epub 2013 Aug 27. No abstract available.

PMID:
23986077
37.

The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE-/- mice.

Gut N, Piecha G, Pradel A, Geldyyev A, Potemkina A, Ritz E, Regele H, Schmitt CP, Gross-Weissmann ML.

Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F277-85. doi: 10.1152/ajprenal.00514.2012. Epub 2013 May 22.

38.

miRNA profiling discriminates types of rejection and injury in human renal allografts.

Wilflingseder J, Regele H, Perco P, Kainz A, Soleiman A, Mühlbacher F, Mayer B, Oberbauer R.

Transplantation. 2013 Mar 27;95(6):835-41. doi: 10.1097/TP.0b013e318280b385.

39.

Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts.

Mengel M, Chan S, Climenhaga J, Kushner YB, Regele H, Colvin RB, Randhawa P.

Am J Transplant. 2013 May;13(5):1235-45. doi: 10.1111/ajt.12193. Epub 2013 Mar 6.

40.

Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.

Bartel G, Wahrmann M, Schwaiger E, Kikić Ž, Winzer C, Hörl WH, Mühlbacher F, Hoke M, Zlabinger GJ, Regele H, Böhmig GA.

Transpl Int. 2013 Feb;26(2):121-30. doi: 10.1111/tri.12000. Epub 2012 Nov 12.

41.

Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease.

Finsterer J, Höftberger R, Stöllberger C, Wöhrer A, Regele H.

J Oncol Pharm Pract. 2013 Jun;19(2):170-4. doi: 10.1177/1078155212443991. Epub 2012 Apr 13.

PMID:
22504167
42.

The cutting (w)edge--comparative evaluation of renal baseline biopsies obtained by two different methods.

Bago-Horvath Z, Kozakowski N, Soleiman A, Bodingbauer M, Mühlbacher F, Regele H.

Nephrol Dial Transplant. 2012 Aug;27(8):3241-8. doi: 10.1093/ndt/gfs066. Epub 2012 Apr 6.

PMID:
22492825
43.

Non-HLA antibodies in kidney allograft rejection: convincing concept in need of further evidence.

Regele H.

Kidney Int. 2011 Mar;79(6):583-586. doi: 10.1038/ki.2010.517.

44.

Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies.

Kikić Z, Regele H, Nordmeyer V, Wahrmann M, Kletzmayr J, Bartel G, Böhmig GA.

Transplantation. 2011 Feb 27;91(4):440-6. doi: 10.1097/TP.0b013e3182052be8.

PMID:
21127459
45.

The pathology of chronic allograft dysfunction.

Racusen LC, Regele H.

Kidney Int Suppl. 2010 Dec;(119):S27-32. doi: 10.1038/ki.2010.419. Review.

46.

Intrarenal production of B-cell survival factors in human lupus nephritis.

Neusser MA, Lindenmeyer MT, Edenhofer I, Gaiser S, Kretzler M, Regele H, Segerer S, Cohen CD.

Mod Pathol. 2011 Jan;24(1):98-107. doi: 10.1038/modpathol.2010.184. Epub 2010 Oct 1.

47.

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation.

Bartel G, Wahrmann M, Regele H, Kikić Z, Fischer G, Druml W, Mühlbacher F, Böhmig GA.

Am J Transplant. 2010 Sep;10(9):2033-42. doi: 10.1111/j.1600-6143.2010.03226.x.

48.

Expression of the chemokine receptor CCR6 in human renal inflammation.

Welsh-Bacic D, Lindenmeyer M, Cohen CD, Draganovici D, Mandelbaum J, Edenhofer I, Ziegler U, Regele H, Wüthrich RP, Segerer S.

Nephrol Dial Transplant. 2011 Apr;26(4):1211-20. doi: 10.1093/ndt/gfq560. Epub 2010 Sep 15.

49.

The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection.

Neusser MA, Kraus AK, Regele H, Cohen CD, Fehr T, Kerjaschki D, Wüthrich RP, Penfold ME, Schall T, Segerer S.

Kidney Int. 2010 May;77(9):801-8. doi: 10.1038/ki.2010.6. Epub 2010 Feb 17.

50.

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A.

Am J Transplant. 2010 Mar;10(3):464-71. doi: 10.1111/j.1600-6143.2009.02987.x. Epub 2010 Jan 29.

Supplemental Content

Loading ...
Support Center